Ultralife Corporation
NasdaqGM:ULBI Rapporto sulle azioni
Cap. di mercato: US$133.0m
Ultralife Dividendi e riacquisti
Dividendo criteri di controllo 0/6 Ultralife non ha registrato alcun pagamento di dividendi.
Informazioni chiave
n/a
Rendimento del dividendo
-2.3%
Rendimento del riacquisto
Rendimento totale per gli azionisti -2.3% Rendimento futuro dei dividendi n/a Crescita dei dividendi n/a Prossima data di pagamento dei dividendi n/a Data di stacco del dividendo n/a Dividendo per azione n/a Rapporto di remunerazione n/a
Aggiornamenti recenti su dividendi e riacquisti
Mostra tutti gli aggiornamenti
Ultralife Corporation to Report Q3, 2024 Results on Nov 08, 2024 Oct 24 Ultralife Corporation (NasdaqGM:ULBI) signed a stock purchase agreement to acquire Electrochem Solutions, Inc. from Integer Holdings Corporation (NYSE:ITGR) for $50 million. Oct 01
Should You Think About Buying Ultralife Corporation (NASDAQ:ULBI) Now? Sep 07
Ultralife: I Bought The Dip; Here Comes The Growth Aug 03
Ultralife's (NASDAQ:ULBI) Earnings Are Weaker Than They Seem Aug 01
Ultralife Corporation to Report Q2, 2024 Results on Jul 25, 2024 Jul 12
Ultralife Corporation Is Attractive Here Jun 30
Ultralife Corporation, Annual General Meeting, Jul 16, 2024 May 31
Investor sentiment improves as stock rises 17% May 03
Price target decreased by 7.7% to US$12.00 Apr 28
First quarter 2024 earnings: EPS and revenues exceed analyst expectations Apr 26
Ultralife Corporation: Ready To Surge Apr 22
These 4 Measures Indicate That Ultralife (NASDAQ:ULBI) Is Using Debt Reasonably Well Apr 16
Ultralife Corporation to Report Q1, 2024 Results on Apr 25, 2024 Apr 12
Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022) Mar 23
Slowing Rates Of Return At Ultralife (NASDAQ:ULBI) Leave Little Room For Excitement Mar 14
Full year 2023 earnings released: EPS: US$0.44 (vs US$0.007 loss in FY 2022) Feb 18
Investor sentiment improves as stock rises 15% Feb 15
Insufficient Growth At Ultralife Corporation (NASDAQ:ULBI) Hampers Share Price Feb 11
New major risk - Revenue and earnings growth Feb 09
Ultralife Corporation to Report Q4, 2023 Results on Feb 15, 2024 Jan 30
Independent Chairman recently bought US$111k worth of stock Dec 11
Independent Chairman recently bought US$181k worth of stock Dec 01
Independent Chairman recently bought US$99k worth of stock Nov 03
Investor sentiment deteriorates as stock falls 19% Nov 02
Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations Oct 26
Is Now An Opportune Moment To Examine Ultralife Corporation (NASDAQ:ULBI)? Oct 26
Ultralife Corporation to Report Q3, 2023 Results on Oct 26, 2023 Oct 13
Investor sentiment improves as stock rises 18% Oct 02
Ultralife (NASDAQ:ULBI) May Have Issues Allocating Its Capital Sep 22
Independent Chairman recently bought US$112k worth of stock Sep 18
Investor sentiment improves as stock rises 27% Aug 22
Consensus revenue estimates increase by 12% Aug 09
New major risk - Share price stability Jul 29
Second quarter 2023 earnings: EPS and revenues exceed analyst expectations Jul 28
Ultralife Corporation to Report Q2, 2023 Results on Jul 27, 2023 Jul 14
Independent Chairman recently bought US$398k worth of stock Jun 18
Ultralife (NASDAQ:ULBI) Takes On Some Risk With Its Use Of Debt Jun 08
Independent Chairman recently bought US$146k worth of stock Jun 04
Ultralife Corporation, Annual General Meeting, Jul 19, 2023 May 31
Independent Chairman recently bought US$117k worth of stock May 14
Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021) Apr 06
Independent Chairman recently bought US$122k worth of stock Mar 19
Full year 2022 earnings released: US$0.007 loss per share (vs US$0.015 loss in FY 2021) Mar 03
Independent Chairman recently bought US$279k worth of stock Dec 12 Ultralife Corporation Announces Executive Changes
Price target increased to US$12.00 Nov 17
Insufficient new directors Nov 17
Third quarter 2022 earnings: EPS misses analyst expectations Oct 27
Ultralife Corporation to Report Q3, 2022 Results on Oct 27, 2022 Oct 14
Ultralife (NASDAQ:ULBI) Is Carrying A Fair Bit Of Debt Sep 27
Ultralife secures $7.5M communications systems contract Sep 22
Independent Chairman recently bought US$158k worth of stock Aug 21
Independent Chairman recently bought US$467k worth of stock Aug 06
Second quarter 2022 earnings: EPS and revenues exceed analyst expectations Jul 28
Ultralife receives $4.6M communications systems VAA order Jul 26 Ultralife Corporation to Report Q2, 2022 Results on Jul 28, 2022 Jul 15
Independent Chairman recently bought US$219k worth of stock Jun 11
Ultralife Corporation, Annual General Meeting, Jul 20, 2022 Jun 01
First quarter 2022 earnings: EPS and revenues exceed analyst expectations Apr 29
Insufficient new directors Apr 27
Ultralife Corporation to Report Q1, 2022 Results on Apr 28, 2022 Apr 15
Does Ultralife (NASDAQ:ULBI) Have A Healthy Balance Sheet? Apr 15
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Mar 11
Independent Chairman recently bought US$245k worth of stock Mar 06
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Feb 05
Consensus revenue estimates fall by 14% Dec 22
Investor sentiment improved over the past week Dec 18
Ultralife Corporation (NasdaqGM:ULBI) acquired Excell Battery Company for $23.5 million. Dec 15
Third quarter 2021 earnings released: US$0.036 loss per share (vs US$0.026 profit in 3Q 2020) Oct 30
Independent Chairman recently bought US$199k worth of stock Aug 06
Second quarter 2021 earnings released: EPS US$0.051 (vs US$0.10 in 2Q 2020) Jul 30
We Think Ultralife Corporation's (NASDAQ:ULBI) CEO Compensation Package Needs To Be Put Under A Microscope Jul 15 Ultralife Corporation(NasdaqGM:ULBI) dropped from Russell 2000 Defensive Index
Investor sentiment improved over the past week May 19
First quarter 2021 earnings released: EPS US$0.042 (vs US$0.067 in 1Q 2020) May 01
Is Ultralife Corporation (NASDAQ:ULBI) Potentially Undervalued? Apr 14
Investor sentiment improved over the past week Mar 12
New 90-day high: US$7.79 Mar 11
The Trends At Ultralife (NASDAQ:ULBI) That You Should Know About Mar 09
CFO, Treasurer & Corporate Secretary exercised options to buy US$155k worth of stock. Mar 07
Ultralife Corporation's (NASDAQ:ULBI) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? Feb 18
Investor sentiment improved over the past week Feb 11
Full year 2020 earnings released Feb 06
Ultralife reports Q4 results Feb 04
If You Had Bought Ultralife (NASDAQ:ULBI) Stock Five Years Ago, You Could Pocket A 17% Gain Today Feb 03
Stabilità e crescita dei pagamenti
Recupero dei dati sui dividendi
Dividendo stabile: Dati insufficienti per determinare se i dividendi per azione di ULBI siano rimasti stabili in passato.
Dividendo in crescita: Dati insufficienti per determinare se i pagamenti dei dividendi di ULBI siano aumentati.
Rendimento dei dividendi rispetto al mercato Ultralife Rendimento dei dividendi rispetto al mercato
Come si colloca il rendimento da dividendo di ULBI rispetto al mercato? Segmento Rendimento dei dividendi Azienda (ULBI) n/a Fondo del 25% del mercato (US) 1.4% Top 25% del mercato (US) 4.4% Media del settore (Electrical) 1.0% Analista previsionale (ULBI) (fino a 3 anni) n/a
Dividendo notevole: Impossibile valutare il rendimento dei dividendi di ULBI rispetto al 25% inferiore dei pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.
Dividendo elevato: Impossibile valutare il rendimento dei dividendi di ULBI rispetto al 25% dei maggiori pagatori di dividendi, poiché la società non ha segnalato alcun pagamento recente.
Distribuzione degli utili agli azionisti
Copertura degli utili: Dati insufficienti per calcolare il payout ratio di ULBI per determinare se i suoi pagamenti di dividendi sono coperti dagli utili.
Pagamenti in contanti agli azionisti
Copertura del flusso di cassa: Impossibile calcolare la sostenibilità dei dividendi poiché ULBI non ha segnalato alcun pagamento.
Scoprire le società che pagano dividendi forti Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
